Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MECP2 | P51608 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.41 |
| ▸ | AXL | P30530 | 1/20 | 0.41 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.41 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10523764 | 0.90 | NOS3 (0.46) | MECP2MAOAMAP4K4MEN1PSIP1 | |
| SCHEMBL105809 | 0.87 | NPC1 (0.41) | — | |
| SCHEMBL20410845 | 0.83 | NPC1 (0.39) | — | |
| SCHEMBL10520530 | 0.80 | KCNH2 (0.38) | — | |
| Carbimide SCHEMBL29055881 | 0.80 | NPC1 (0.37) | — | |
| SCHEMBL27260114 | 0.80 | NISCH (0.46) | MAOA | |
| SCHEMBL23054974 | 0.79 | KCNH2 (0.37) | — | |
| SCHEMBL1338566 | 0.79 | NISCH (0.47) | ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL29364765 | 0.79 | CHRNB4 (0.47) | MEN1KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL4751753 | 0.79 | CHRNB4 (0.47) | ALDH1A1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010018516-A1 | Oxazoline or oxazine acetoacetate aqueous coating compositions | BASF CORPORATION | 2001-08-30 | — | — | US | disclosed |
| US-6235901-B1 | CAN BE POLYMERIZED AND/OR COPOLYMERIZED BY CATONIC POLYMERIZATION; CAN BE CROSSLINKED AND ARE USEFUL IN COATINGS, INKS, OVERPRINT VARNISHES, AND SURFACE TREATMENT APPLICATIONS. | S. C. JOHNSON COMMERCIAL MARKETS, INC. | 2001-05-22 | — | — | US | disclosed |
| WO-2000068212-A1 | OXAZOLINE OR OXAZINE ACETOACETATE AQUEOUS COATING COMPOSITIONS | S. C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 2000-11-16 | — | — | WO | disclosed |
| US-5491201-A | HEAT/CHEMICAL RESISTANCE; HIGH MECHANICAL STRENGTH | THE DOW CHEMICAL COMPANY (US) | 1996-02-13 | — | — | US | disclosed |
| US-5338828-A | Mesogenic cyclic imino ether-containing compositions and polymerization products thereof | THE DOW CHEMICAL COMPANY (US) | 1994-08-16 | — | — | US | disclosed |
| US-5281675-A | Liquid crystal polymers | THE DOW CHEMICAL COMPANY (US) | 1994-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018516-A1 | Oxazoline or oxazine acetoacetate aqueous coating compositions | ITGB7, DNMT3A, KAT7 | MECP2 72/4885MAOA 555/4885MAP4K4 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.